His condition is considered "quite serious" as he experiences pauses in his breathing 59 times an hour while he is asleep. The normal range is five times an hour.

Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe ...

A cat named Lottie might have taken things a step too far when she wasn't getting the attention she wanted. Instead of ...

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

CT BUZZ Reporter Jillian Andrews recently spoke with Dr. Zubin Bham, MD a Sleep Medicine specialist from Bridgeport Hospital, about Maskless Sleep Apnea Treatments.For ...

The Let’s Talk Smiles podcast announces its upcoming episode on sleep-related health issues, featuring sleep expert and ...

New research provides guidance on the effects of caffeine, diet and naps on sleep. Plus there are expanded treatments for ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Try a single issue or save on a subscription Issues delivered straight to your door or device ...